HRS-5346

DRUG3 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Lipoprotein DisorderTreatment of Lipoprotein Disorder

Phase 1

Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants

Not yet recruitingNCT07752069

Shandong Suncadia Medicine Co., Ltd.Lipoprotein Disorder

Start: 2026-08-01End: 2026-10-01Target: 50Updated: 2026-08-07

Phase 2

A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

CompletedNCT06816264

Shandong Suncadia Medicine Co., Ltd.Treatment of Lipoprotein Disorder

Start: 2025-02-18End: 2025-09-29Updated: 2025-11-17

Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events

Not yet recruitingNCT07767513

Shandong Suncadia Medicine Co., Ltd.Lipoprotein Disorder

Start: 2026-09-01End: 2027-05-01Target: 60Updated: 2026-08-17